Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5181220
Max Phase: Preclinical
Molecular Formula: C14H12O4
Molecular Weight: 244.25
Associated Items:
ID: ALA5181220
Max Phase: Preclinical
Molecular Formula: C14H12O4
Molecular Weight: 244.25
Associated Items:
Canonical SMILES: C=C(C)[C@@H]1Cc2c(cc3oc(=O)ccc3c2O)O1
Standard InChI: InChI=1S/C14H12O4/c1-7(2)10-5-9-12(17-10)6-11-8(14(9)16)3-4-13(15)18-11/h3-4,6,10,16H,1,5H2,2H3/t10-/m0/s1
Standard InChI Key: KGVOEEZUDJJYRJ-JTQLQIEISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 244.25 | Molecular Weight (Monoisotopic): 244.0736 | AlogP: 2.38 | #Rotatable Bonds: 1 |
Polar Surface Area: 59.67 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.73 | CX Basic pKa: | CX LogP: 2.40 | CX LogD: 2.23 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.62 | Np Likeness Score: 2.08 |
1. Popović-Djordjević J, Quispe C, Giordo R, Kostić A, Katanić Stanković JS, Tsouh Fokou PV, Carbone K, Martorell M, Kumar M, Pintus G, Sharifi-Rad J, Docea AO, Calina D.. (2022) Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs., 233 [PMID:35276425] [10.1016/j.ejmech.2022.114217] |
Source(1):